IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 76 filers reported holding IMMUNOMEDICS INC in Q1 2014. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $310,196,000 | +105.0% | 3,648,078 | -14.6% | 0.02% | +90.9% |
Q2 2020 | $151,317,000 | +58.6% | 4,269,661 | -39.7% | 0.01% | +37.5% |
Q1 2020 | $95,381,000 | -33.5% | 7,075,710 | +4.3% | 0.01% | -20.0% |
Q4 2019 | $143,506,000 | +64.2% | 6,781,951 | +2.9% | 0.01% | +42.9% |
Q3 2019 | $87,386,000 | -23.0% | 6,590,176 | -19.4% | 0.01% | -12.5% |
Q2 2019 | $113,472,000 | -16.5% | 8,181,125 | +15.6% | 0.01% | -27.3% |
Q1 2019 | $135,925,000 | +72.2% | 7,075,737 | +27.9% | 0.01% | +57.1% |
Q4 2018 | $78,953,000 | -33.7% | 5,532,786 | -3.2% | 0.01% | -22.2% |
Q3 2018 | $119,047,000 | -5.6% | 5,715,435 | +7.3% | 0.01% | -18.2% |
Q2 2018 | $126,082,000 | +36.5% | 5,326,578 | -15.8% | 0.01% | +37.5% |
Q1 2018 | $92,377,000 | -10.6% | 6,322,848 | -1.2% | 0.01% | 0.0% |
Q4 2017 | $103,374,000 | +55.6% | 6,396,893 | +34.6% | 0.01% | +33.3% |
Q3 2017 | $66,419,000 | +56.1% | 4,751,015 | -1.4% | 0.01% | +50.0% |
Q2 2017 | $42,549,000 | +87.2% | 4,818,847 | +37.2% | 0.00% | +100.0% |
Q1 2017 | $22,730,000 | +284.5% | 3,513,549 | +118.2% | 0.00% | +100.0% |
Q4 2016 | $5,911,000 | +27.1% | 1,610,194 | +12.5% | 0.00% | – |
Q3 2016 | $4,651,000 | -14.9% | 1,431,793 | -39.2% | 0.00% | -100.0% |
Q2 2016 | $5,463,000 | +51.4% | 2,354,732 | +63.3% | 0.00% | – |
Q1 2016 | $3,609,000 | -10.4% | 1,442,360 | +9.9% | 0.00% | – |
Q4 2015 | $4,029,000 | +79.8% | 1,312,013 | +0.8% | 0.00% | – |
Q3 2015 | $2,241,000 | -58.1% | 1,301,999 | -1.0% | 0.00% | -100.0% |
Q2 2015 | $5,347,000 | +9.3% | 1,315,589 | +3.0% | 0.00% | 0.0% |
Q1 2015 | $4,892,000 | -20.3% | 1,277,338 | -0.1% | 0.00% | 0.0% |
Q4 2014 | $6,139,000 | +29.5% | 1,278,710 | +0.3% | 0.00% | 0.0% |
Q3 2014 | $4,740,000 | +0.1% | 1,275,023 | -1.7% | 0.00% | 0.0% |
Q2 2014 | $4,735,000 | -14.1% | 1,297,298 | -0.9% | 0.00% | 0.0% |
Q1 2014 | $5,514,000 | -40.6% | 1,309,352 | -46.5% | 0.00% | 0.0% |
Q4 2013 | $9,277,000 | +20.3% | 2,447,706 | +96.4% | 0.00% | 0.0% |
Q3 2013 | $7,713,000 | +16.4% | 1,246,151 | +2.3% | 0.00% | 0.0% |
Q2 2013 | $6,627,000 | – | 1,218,461 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |